Astellas Drops Suit Over Medicare Drug Price Negotiation Law

By Theresa Schliep · September 7, 2023, 9:13 PM EDT

Astellas Pharma on Wednesday dropped its challenge to the new Medicare drug price negotiation program after none of its products were selected for negotiation by the U.S. Department of Health and...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Notice

Case Information

Case Title

Astellas Pharma US, Inc. v. Department of Health and Human Services et al

Case Number

Court

Illinois Northern

Nature of Suit

440(Civil Rights: Other)

Date Filed

July 14, 2023

Recent Articles By Theresa

November 25, 2024
Hormone Therapy Co. Jilted Actress Over Image Use, Suit Says
November 25, 2024
Ex-Epstein Becker Healthcare Ace Joins Polsinelli Team
November 19, 2024
Nonpracticing Doc Can't Testify In Med Mal Case, Court Says
November 15, 2024
Despite Vaccine Spotlight, RFK Jr. A Health Policy 'Unknown'
November 14, 2024
Trump Picks RFK Jr. To Lead Health & Human Services
November 12, 2024
Why The CDC May Look Very Different In Trump's 2nd Term
November 05, 2024
Abortion Ballot Tracker: 7 States Add Protections As Fla. Effort Fails
October 29, 2024
Fla. Health Agency's All-Out Battle Against Abortion Measure
October 24, 2024
'Will Of The People' Upheld With Ohio Abortion Ban Quashed
October 22, 2024
A Tenn. Court Gets Specific On Abortion Ban Exceptions